A randomized trial to evaluate the impact of copra meal hydrolysate on gastrointestinal symptoms and gut microbiome
The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult participants, aged 18–40 years were assigned to daily consume 3 g of CMH, 5 g of CMH or placebo in the form of drink powder for 21 days. Consumption of...
Saved in:
| Published in | PeerJ (San Francisco, CA) Vol. 9; p. e12158 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
San Diego, USA
PeerJ. Ltd
15.09.2021
PeerJ Inc |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult participants, aged 18–40 years were assigned to daily consume 3 g of CMH, 5 g of CMH or placebo in the form of drink powder for 21 days. Consumption of CMH at 3 g/d improved defecating conditions by reducing stool size and also relieved flatulence and bloating symptoms. Fecal samples were collected serially at the baseline before treatment, after the treatment and after a 2-week washout period. The gut microbiomes were similar among the treatment groups, with microbial community changes observed within the groups. Intake of CMH at 3 g/d led to increase microbial diversity and richness. Reduction of the ratio between
Firmicutes
to
Bacteroidetes
was observed, although it was not significantly different between the groups. The 3 g/d CMH treatment increased beneficial microbes in the group of fiber-degrading bacteria, especially human colonic
Bacteroidetes
, while induction of
Bifidobacteriaceae
was observed after the washout period. Intake of CMH led to increase lactic acid production, while 3 g/d supplement promoted the present of immunoglobulin A (IgA) in stool samples. The 3 g daily dose of CMH led to the potentially beneficial effects on gut health for healthy individuals. |
|---|---|
| AbstractList | The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult participants, aged 18-40 years were assigned to daily consume 3 g of CMH, 5 g of CMH or placebo in the form of drink powder for 21 days. Consumption of CMH at 3 g/d improved defecating conditions by reducing stool size and also relieved flatulence and bloating symptoms. Fecal samples were collected serially at the baseline before treatment, after the treatment and after a 2-week washout period. The gut microbiomes were similar among the treatment groups, with microbial community changes observed within the groups. Intake of CMH at 3 g/d led to increase microbial diversity and richness. Reduction of the ratio between Firmicutes to Bacteroidetes was observed, although it was not significantly different between the groups. The 3 g/d CMH treatment increased beneficial microbes in the group of fiber-degrading bacteria, especially human colonic Bacteroidetes, while induction of Bifidobacteriaceae was observed after the washout period. Intake of CMH led to increase lactic acid production, while 3 g/d supplement promoted the present of immunoglobulin A (IgA) in stool samples. The 3 g daily dose of CMH led to the potentially beneficial effects on gut health for healthy individuals. The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult participants, aged 18–40 years were assigned to daily consume 3 g of CMH, 5 g of CMH or placebo in the form of drink powder for 21 days. Consumption of CMH at 3 g/d improved defecating conditions by reducing stool size and also relieved flatulence and bloating symptoms. Fecal samples were collected serially at the baseline before treatment, after the treatment and after a 2-week washout period. The gut microbiomes were similar among the treatment groups, with microbial community changes observed within the groups. Intake of CMH at 3 g/d led to increase microbial diversity and richness. Reduction of the ratio between Firmicutes to Bacteroidetes was observed, although it was not significantly different between the groups. The 3 g/d CMH treatment increased beneficial microbes in the group of fiber-degrading bacteria, especially human colonic Bacteroidetes , while induction of Bifidobacteriaceae was observed after the washout period. Intake of CMH led to increase lactic acid production, while 3 g/d supplement promoted the present of immunoglobulin A (IgA) in stool samples. The 3 g daily dose of CMH led to the potentially beneficial effects on gut health for healthy individuals. The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult participants, aged 18-40 years were assigned to daily consume 3 g of CMH, 5 g of CMH or placebo in the form of drink powder for 21 days. Consumption of CMH at 3 g/d improved defecating conditions by reducing stool size and also relieved flatulence and bloating symptoms. Fecal samples were collected serially at the baseline before treatment, after the treatment and after a 2-week washout period. The gut microbiomes were similar among the treatment groups, with microbial community changes observed within the groups. Intake of CMH at 3 g/d led to increase microbial diversity and richness. Reduction of the ratio between Firmicutes to Bacteroidetes was observed, although it was not significantly different between the groups. The 3 g/d CMH treatment increased beneficial microbes in the group of fiber-degrading bacteria, especially human colonic Bacteroidetes, while induction of Bifidobacteriaceae was observed after the washout period. Intake of CMH led to increase lactic acid production, while 3 g/d supplement promoted the present of immunoglobulin A (IgA) in stool samples. The 3 g daily dose of CMH led to the potentially beneficial effects on gut health for healthy individuals.The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult participants, aged 18-40 years were assigned to daily consume 3 g of CMH, 5 g of CMH or placebo in the form of drink powder for 21 days. Consumption of CMH at 3 g/d improved defecating conditions by reducing stool size and also relieved flatulence and bloating symptoms. Fecal samples were collected serially at the baseline before treatment, after the treatment and after a 2-week washout period. The gut microbiomes were similar among the treatment groups, with microbial community changes observed within the groups. Intake of CMH at 3 g/d led to increase microbial diversity and richness. Reduction of the ratio between Firmicutes to Bacteroidetes was observed, although it was not significantly different between the groups. The 3 g/d CMH treatment increased beneficial microbes in the group of fiber-degrading bacteria, especially human colonic Bacteroidetes, while induction of Bifidobacteriaceae was observed after the washout period. Intake of CMH led to increase lactic acid production, while 3 g/d supplement promoted the present of immunoglobulin A (IgA) in stool samples. The 3 g daily dose of CMH led to the potentially beneficial effects on gut health for healthy individuals. |
| ArticleNumber | e12158 |
| Audience | Academic |
| Author | Nitisinprasert, Sunee Suratannon, Narissara Sathitkowitchai, Witida Weerapakorn, Wanlapa Patumcharoenpol, Preecha Keawsompong, Suttipun Nakphaichit, Massalin |
| Author_xml | – sequence: 1 givenname: Witida surname: Sathitkowitchai fullname: Sathitkowitchai, Witida organization: Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok, Thailand, Center for Advanced Studies for Agriculture and Food, Kasetsart University Institute for Advanced Studies, Kasetsart University, Bangkok, Thailand, Microarray Research Team, National Center for Genetic Engineering and Biotechnology, Thailand Science Park, Pathum Thani, Thailand – sequence: 2 givenname: Narissara surname: Suratannon fullname: Suratannon, Narissara organization: Pediatric Allergy & Clinical Immunology Research Unit, Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand – sequence: 3 givenname: Suttipun surname: Keawsompong fullname: Keawsompong, Suttipun organization: Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok, Thailand, Center for Advanced Studies for Agriculture and Food, Kasetsart University Institute for Advanced Studies, Kasetsart University, Bangkok, Thailand – sequence: 4 givenname: Wanlapa surname: Weerapakorn fullname: Weerapakorn, Wanlapa organization: Pediatric Allergy & Clinical Immunology Research Unit, Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand – sequence: 5 givenname: Preecha surname: Patumcharoenpol fullname: Patumcharoenpol, Preecha organization: Interdisciplinary Graduate Program in Bioscience, Faculty of Science, Kasetsart University, Bangkok, Thailand – sequence: 6 givenname: Sunee surname: Nitisinprasert fullname: Nitisinprasert, Sunee organization: Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok, Thailand, Center for Advanced Studies for Agriculture and Food, Kasetsart University Institute for Advanced Studies, Kasetsart University, Bangkok, Thailand – sequence: 7 givenname: Massalin surname: Nakphaichit fullname: Nakphaichit, Massalin organization: Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok, Thailand, Center for Advanced Studies for Agriculture and Food, Kasetsart University Institute for Advanced Studies, Kasetsart University, Bangkok, Thailand |
| BookMark | eNptkltrHCEUgIeS0qRpnvoHhEIplN2qc9F5KSyhl0CgL-2znNHjrMvMOFUnsP31dXdDyZbog3L8zsdRz-viYvITFsVbRtdCMPFpRgy7NeOsli-KK84asZJl3V482V8WNzHuaB6SN1SWr4rLsmpY0zB5VcQNCTAZP7o_aEgKDgaSPMEHGBZISNIWiRtn0Il4S7SfA5ARM7Tdm-CHfTxAfiI9xBS8mxLG5KZ8HvfjnPwYSbaTfklkdDr4zvkR3xQvLQwRbx7X6-LX1y8_b7-v7n98u7vd3K90zXladaUA3QHVNWtbTbmgmleGg9DWCNpKqMC00pTYGgudZSVSCbY2nW5Z1aIur4u7k9d42Kk5uBHCXnlw6hjwoVcQktMDKk45UGal5rSrJCsl8o42KLu2KY3WNrs-n1zz0o1oNE4pwHAmPT-Z3Fb1_kHJqmrrkmfBh0dB8L-X_EpqdFHjMMCEfomK15JSXgsuMvruhPaQS3OT9dmoD7jaNKLO9QkhM7V-hsrTYH7q3CXW5fhZwvsnCdv8iWkb_bAk56d4Dn48gfnDYgxo_12TUXXoOnXsOnXsukyz_2jtEhykuR43PJvzF9aj3iU |
| CitedBy_id | crossref_primary_10_1007_s00394_022_02802_5 crossref_primary_10_1371_journal_pone_0288286 crossref_primary_10_1038_s41366_024_01590_8 crossref_primary_10_1016_j_bcab_2022_102522 crossref_primary_10_1016_j_cofs_2022_100883 crossref_primary_10_1016_j_foodres_2023_113288 crossref_primary_10_1080_10408398_2023_2222165 crossref_primary_10_14202_vetworld_2023_1627_1635 crossref_primary_10_3390_ani14111677 crossref_primary_10_3390_ani14111689 crossref_primary_10_1128_spectrum_01599_24 crossref_primary_10_3389_fmicb_2025_1529081 crossref_primary_10_3390_biology12010021 crossref_primary_10_1146_annurev_food_052720_114503 |
| Cites_doi | 10.1155/2018/4095789 10.1248/jhs.52.329 10.1186/s40064-015-1565-7 10.1002/oby.20466 10.3136/fstr.10.93 10.1007/s13205-019-1633-8 10.1007/s11274-007-9627-9 10.4161/gmic.19897 10.7717/peerj.7661 10.1248/jhs.52.482 10.3945/ajcn.114.092064 10.1111/apa.14620 10.3136/fstr.10.195 10.3402/fnr.v45i0.1790 10.3390/nu12041107 10.3748/wjg.v20.i37.13446 10.1093/ajcn/nqy376 10.1038/nrgastro.2017.75 10.3136/fstr.10.174 10.3389/fmicb.2018.00001 10.1007/s13205-017-1058-1 10.1007/s13205-018-1178-2 10.1186/1756-0500-7-50 10.1155/2018/40957899 10.1177/1756283x12459294 10.1079/BJNBJN/2002530 10.1038/nrmicro1817 10.1002/jssc.201900249 10.1038/s41587-019-0209-9 10.1093/cdn/nzy005 10.1136/gut.28.10.124 10.1038/s41587-020-0548-6 10.1371/journal.pone.0028010 10.1039/c8fo00209f |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2021 PeerJ. Ltd. 2021 Sathitkowitchai et al. 2021 Sathitkowitchai et al. 2021 Sathitkowitchai et al. |
| Copyright_xml | – notice: COPYRIGHT 2021 PeerJ. Ltd. – notice: 2021 Sathitkowitchai et al. – notice: 2021 Sathitkowitchai et al. 2021 Sathitkowitchai et al. |
| DBID | AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.7717/peerj.12158 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2167-8359 |
| ExternalDocumentID | oai_doaj_org_article_202a01f8c20b48138e2b06e8b963dccf PMC8449532 A675481778 10_7717_peerj_12158 |
| GeographicLocations | Thailand |
| GeographicLocations_xml | – name: Thailand |
| GrantInformation_xml | – fundername: Kasetsart University Institute for Advanced Studies, Kasetsart University – fundername: National Research Council of Thailand (NRCT) – fundername: Center for Advanced Studies for Agriculture and Food (CASAF) |
| GroupedDBID | 53G 5VS 88I 8FE 8FH AAFWJ AAYXX ABUWG ADBBV ADRAZ AENEX AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION DIK DWQXO ECGQY GNUQQ GROUPED_DOAJ GX1 H13 HCIFZ HYE IAO IEA IHR IHW ITC KQ8 LK8 M2P M48 M7P M~E OK1 PHGZM PHGZT PIMPY PQQKQ PROAC RPM W2D YAO PMFND 7X8 PQGLB 5PM PUEGO |
| ID | FETCH-LOGICAL-c522t-b37acba0c5199c0270c24d2a7cfd7098a4ad98d3e9dfabf13e08af5dbc9149ec3 |
| IEDL.DBID | M48 |
| ISSN | 2167-8359 |
| IngestDate | Wed Aug 27 01:15:35 EDT 2025 Thu Aug 21 18:41:45 EDT 2025 Fri Jul 11 08:53:33 EDT 2025 Tue Jun 17 20:56:47 EDT 2025 Tue Jun 10 20:19:40 EDT 2025 Thu May 22 21:12:41 EDT 2025 Thu Apr 24 23:11:13 EDT 2025 Tue Jul 01 01:25:36 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c522t-b37acba0c5199c0270c24d2a7cfd7098a4ad98d3e9dfabf13e08af5dbc9149ec3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/202a01f8c20b48138e2b06e8b963dccf |
| PMID | 34616618 |
| PQID | 2580025727 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_202a01f8c20b48138e2b06e8b963dccf pubmedcentral_primary_oai_pubmedcentral_nih_gov_8449532 proquest_miscellaneous_2580025727 gale_infotracmisc_A675481778 gale_infotracacademiconefile_A675481778 gale_healthsolutions_A675481778 crossref_primary_10_7717_peerj_12158 crossref_citationtrail_10_7717_peerj_12158 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-09-15 |
| PublicationDateYYYYMMDD | 2021-09-15 |
| PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | San Diego, USA |
| PublicationPlace_xml | – name: San Diego, USA |
| PublicationTitle | PeerJ (San Francisco, CA) |
| PublicationYear | 2021 |
| Publisher | PeerJ. Ltd PeerJ Inc |
| Publisher_xml | – name: PeerJ. Ltd – name: PeerJ Inc |
| References | Jarett (10.7717/peerj.12158/ref-16) 2019; 7 Scholtens (10.7717/peerj.12158/ref-29) 2014; 20 Douglas (10.7717/peerj.12158/ref-10) 2020; 38 Kisuse (10.7717/peerj.12158/ref-17) 2018; 9 Bolyen (10.7717/peerj.12158/ref-5) 2019; 37 Pangsri (10.7717/peerj.12158/ref-24) 2015; 4 Flint (10.7717/peerj.12158/ref-11) 2008; 6 Walton (10.7717/peerj.12158/ref-35) 2010; 5 Andersson (10.7717/peerj.12158/ref-1) 2001; 45 Asano (10.7717/peerj.12158/ref-2) 2006; 55 Bannister (10.7717/peerj.12158/ref-4) 1987; 28 Hemarajata (10.7717/peerj.12158/ref-14) 2013; 6 Wang (10.7717/peerj.12158/ref-36) 2019; 42 Topping (10.7717/peerj.12158/ref-31) 1996; 5 Wilson (10.7717/peerj.12158/ref-38) 2019; 109 Kumao (10.7717/peerj.12158/ref-18) 2006; 52 Prayoonthien (10.7717/peerj.12158/ref-26) 2018; 8 Piemontese (10.7717/peerj.12158/ref-25) 2011; 6 Wang (10.7717/peerj.12158/ref-37) 2018; 9 Castaner (10.7717/peerj.12158/ref-8) 2018; 2018 Asano (10.7717/peerj.12158/ref-3) 2004; 10 Holscher (10.7717/peerj.12158/ref-15) 2015; 101 Umemura (10.7717/peerj.12158/ref-32) 2004; 10 Carlson (10.7717/peerj.12158/ref-7) 2018; 2 Prayoonthien (10.7717/peerj.12158/ref-27) 2019; 9 Titapoka (10.7717/peerj.12158/ref-30) 2007; 24 Flint (10.7717/peerj.12158/ref-12) 2012; 3 Kumao (10.7717/peerj.12158/ref-20) 2005; 54 Cummings (10.7717/peerj.12158/ref-9) 2002; 87 Rungruangsaphakun (10.7717/peerj.12158/ref-28) 2018; 8 Callahan (10.7717/peerj.12158/ref-6) 2016; 13 Kumao (10.7717/peerj.12158/ref-19) 2006; 52 Mirsepasi (10.7717/peerj.12158/ref-22) 2014; 7 Umemura (10.7717/peerj.12158/ref-33) 2004; 10 Moretti (10.7717/peerj.12158/ref-23) 2018; 108 Verdam (10.7717/peerj.12158/ref-34) 2013; 21 Markowiak-Kopeć (10.7717/peerj.12158/ref-21) 2020; 12 Gibson (10.7717/peerj.12158/ref-13) 2017; 14 |
| References_xml | – volume: 13 start-page: 581 issue: 7 year: 2016 ident: 10.7717/peerj.12158/ref-6 article-title: DADA2: high-resolution sample inference from Illumina amplicon data publication-title: Nature Methods doi: 10.1155/2018/4095789 – volume: 52 start-page: 329 year: 2006 ident: 10.7717/peerj.12158/ref-18 article-title: Mannooligosaccharides blended coffee beverage intake increases the fat level in feces publication-title: Journal of Health Science doi: 10.1248/jhs.52.329 – volume: 4 start-page: 771 year: 2015 ident: 10.7717/peerj.12158/ref-24 article-title: Characterization of mannanase from Bacillus circulans NT 6.7 and its application in mannooligosaccharides preparation as prebiotic publication-title: Springerplus doi: 10.1186/s40064-015-1565-7 – volume: 21 start-page: 607 year: 2013 ident: 10.7717/peerj.12158/ref-34 article-title: Human intestinal microbiota composition is associated with local and systemic inflammation in obesity publication-title: Obesity doi: 10.1002/oby.20466 – volume: 10 start-page: 93 year: 2004 ident: 10.7717/peerj.12158/ref-3 article-title: Effects of mannooligosaccharides from coffee mannan on fecal microflora and defecation in healthy volunteers publication-title: Food Science and Technology Research doi: 10.3136/fstr.10.93 – volume: 5 start-page: 75 year: 2010 ident: 10.7717/peerj.12158/ref-35 article-title: A double-blind, placebo controlled human study investigating the effects of coffee derived manno-oligosaccharides on the faecal microbiota of a healthy adult population publication-title: International Journal of Probiotics and Prebiotics – volume: 9 start-page: 93 year: 2019 ident: 10.7717/peerj.12158/ref-27 article-title: In vitro fermentation of copra meal hydrolysate by human fecal microbiota publication-title: 3 Biotech doi: 10.1007/s13205-019-1633-8 – volume: 24 start-page: 1425 year: 2007 ident: 10.7717/peerj.12158/ref-30 article-title: Selection and characterization of mannanase-producing bacteria useful for the formation of prebiotic manno-oligosaccharides from copra meal publication-title: World Journal of Microbiology and Biotechnology doi: 10.1007/s11274-007-9627-9 – volume: 3 start-page: 289 year: 2012 ident: 10.7717/peerj.12158/ref-12 article-title: Microbial degradation of complex carbohydrates in the gut publication-title: Gut Microbes doi: 10.4161/gmic.19897 – volume: 7 start-page: e7661 year: 2019 ident: 10.7717/peerj.12158/ref-16 article-title: Diets with and without edible cricket support a similar level of diversity in the gut microbiome of dogs publication-title: PeerJ doi: 10.7717/peerj.7661 – volume: 52 start-page: 482 year: 2006 ident: 10.7717/peerj.12158/ref-19 article-title: Effect of coffee drink containing mannooligosaccharides on total amount of excreted fat in healthy adults publication-title: Journal of Health Science doi: 10.1248/jhs.52.482 – volume: 101 start-page: 55 year: 2015 ident: 10.7717/peerj.12158/ref-15 article-title: Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial publication-title: American Journal of Clinical Nutrition doi: 10.3945/ajcn.114.092064 – volume: 108 start-page: 877 year: 2018 ident: 10.7717/peerj.12158/ref-23 article-title: The bowel movement characteristics of exclusively breastfed and exclusively formula fed infants differ during the first three months of life publication-title: Acta Paediatrica doi: 10.1111/apa.14620 – volume: 10 start-page: 195 year: 2004 ident: 10.7717/peerj.12158/ref-32 article-title: Effect of coffee mix drink containing mannooligosaccharides from coffee mannan on defecation and fecal microbiota in healthy volunteers publication-title: Food Science and Technology Research doi: 10.3136/fstr.10.195 – volume: 45 start-page: 58 year: 2001 ident: 10.7717/peerj.12158/ref-1 article-title: Health effects of probiotics and prebiotics A literature review on human studies publication-title: Food & Nutrition Research doi: 10.3402/fnr.v45i0.1790 – volume: 12 start-page: 1 year: 2020 ident: 10.7717/peerj.12158/ref-21 article-title: The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome publication-title: Nutrients doi: 10.3390/nu12041107 – volume: 20 start-page: 13446 year: 2014 ident: 10.7717/peerj.12158/ref-29 article-title: Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review publication-title: World Journal of Gastroenterology doi: 10.3748/wjg.v20.i37.13446 – volume: 109 start-page: 1098 year: 2019 ident: 10.7717/peerj.12158/ref-38 article-title: Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials publication-title: American Journal of Clinical Nutrition doi: 10.1093/ajcn/nqy376 – volume: 14 start-page: 491 year: 2017 ident: 10.7717/peerj.12158/ref-13 article-title: Dietary prebiotics: expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics publication-title: Nature Reviews Gastroenterology & Hepatology doi: 10.1038/nrgastro.2017.75 – volume: 10 start-page: 174 year: 2004 ident: 10.7717/peerj.12158/ref-33 article-title: Effect of small dose of mannooligosaccharides from coffee mannan on defecating conditions and fecal microflora publication-title: Food Science and Technology Research doi: 10.3136/fstr.10.174 – volume: 54 start-page: 505 year: 2005 ident: 10.7717/peerj.12158/ref-20 article-title: Effects of diets containing mannooligosaccharides from coffee mannan on fat in blood serum and liver fat in (ZUC)-fa/fa rats publication-title: Journal of Pharmaceutical Science and Technology – volume: 9 start-page: 1 year: 2018 ident: 10.7717/peerj.12158/ref-17 article-title: Urban diets linked to gut microbiome and metabolome alterations in children: a comparative cross-sectional study in Thailand publication-title: Frontiers in Microbiology doi: 10.3389/fmicb.2018.00001 – volume: 8 start-page: 41 year: 2018 ident: 10.7717/peerj.12158/ref-26 article-title: In vitro fermentation of copra meal hydrolysate by chicken microbiota publication-title: 3 Biotech doi: 10.1007/s13205-017-1058-1 – volume: 8 start-page: 169 year: 2018 ident: 10.7717/peerj.12158/ref-28 article-title: Optimization of hydrolysis conditions for the mannooligosaccharides copra meal hydrolysate production publication-title: 3 Biotech doi: 10.1007/s13205-018-1178-2 – volume: 7 start-page: 50 year: 2014 ident: 10.7717/peerj.12158/ref-22 article-title: Microbial diversity in fecal samples depends on DNA extraction method: easyMag DNA extraction compared to QIAamp DNA stool mini kit extraction publication-title: BMC Research Notes doi: 10.1186/1756-0500-7-50 – volume: 2018 start-page: 4095789 year: 2018 ident: 10.7717/peerj.12158/ref-8 article-title: The gut microbiome profile in obesity: a systematic review publication-title: International Journal of Endocrinology doi: 10.1155/2018/40957899 – volume: 55 start-page: 93 year: 2006 ident: 10.7717/peerj.12158/ref-2 article-title: Investigation of mannooligosaccharides blended coffee beverage on abdominal fat reduction in humans publication-title: Japanese Journal of Medical and Pharmocologic Science – volume: 6 start-page: 39 year: 2013 ident: 10.7717/peerj.12158/ref-14 article-title: Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation publication-title: Therapeutic Advances in Gastroenterology doi: 10.1177/1756283x12459294 – volume: 87 start-page: S145 issue: Suppl 2 year: 2002 ident: 10.7717/peerj.12158/ref-9 article-title: Gastrointestinal effects of prebiotics publication-title: The British Journal of Nutrition doi: 10.1079/BJNBJN/2002530 – volume: 6 start-page: 121 year: 2008 ident: 10.7717/peerj.12158/ref-11 article-title: Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis publication-title: Nature Reviews Microbiology doi: 10.1038/nrmicro1817 – volume: 42 start-page: 2500 year: 2019 ident: 10.7717/peerj.12158/ref-36 article-title: Simultaneous determination of short-chain fatty acids in human feces by HPLC with ultraviolet detection following chemical derivatization and solid-phase extraction segmental elution publication-title: Journal of Separation Science doi: 10.1002/jssc.201900249 – volume: 37 start-page: 852 issue: 8 year: 2019 ident: 10.7717/peerj.12158/ref-5 article-title: Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 publication-title: Nature Biotechnology doi: 10.1038/s41587-019-0209-9 – volume: 2 start-page: 1 year: 2018 ident: 10.7717/peerj.12158/ref-7 article-title: Health effect and sources of prebiotic dietary fiber publication-title: Current Developments in Nutrition doi: 10.1093/cdn/nzy005 – volume: 28 start-page: 1246 year: 1987 ident: 10.7717/peerj.12158/ref-4 article-title: Effect of stool size and consistency on defecation publication-title: Gut doi: 10.1136/gut.28.10.124 – volume: 38 start-page: 685 year: 2020 ident: 10.7717/peerj.12158/ref-10 article-title: PICRUSt2 for prediction of metagenome functions doi: 10.1038/s41587-020-0548-6 – volume: 6 start-page: e28010 issue: 11 year: 2011 ident: 10.7717/peerj.12158/ref-25 article-title: Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial publication-title: PLOS ONE doi: 10.1371/journal.pone.0028010 – volume: 5 start-page: 15 year: 1996 ident: 10.7717/peerj.12158/ref-31 article-title: Short-chain fatty acids produced by intestinal bacteria publication-title: Asia Pacific Journal of Clinical Nutrition – volume: 9 start-page: 3916 year: 2018 ident: 10.7717/peerj.12158/ref-37 article-title: Mannan-oligosaccharide modulates the obesity and gut microbiota in high-fat diet-fed mice publication-title: Food & Function doi: 10.1039/c8fo00209f |
| SSID | ssj0000826083 |
| Score | 2.3297296 |
| Snippet | The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult... |
| SourceID | doaj pubmedcentral proquest gale crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | e12158 |
| SubjectTerms | Clinical Trials Copra meal hydrolysate Drugs and Devices Gastroenterology and Hepatology Human gut microbiome Immunoglobulin A Mannooligosaccharides Microbiology Prebiotic Short-chain fatty acid |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JLadOWbpuHCoFCwdQr22v5uCkJoZCeGshNSCMp2RJbi-09bH99Z2RnWbeFXnq1Bj80M5pv8Mw3jJ1RTZjAsJA4YSHJrSsSuQCTiFJkuUWDyGIj7fW3xdVN_vW2uN0b9UU1YQM98LBxlJzrdO4liNTkcp5JJ0y6cNKg5VgAT6cvxry9ZCqewYiaEVwMDXklpiyf1861PyKXgpyEoMjU_-d5_HuN5F7QuXzBno9okS-Ht3zJnrjmkD29Hv-Hv2LdkmOssaFe_XSWxwkcvA98pPB2HNEdH_ogefAcwrrVvEZoyO-3tg0P246EQsPvdNe3gagj0OPpid22Xveh7jjend9tel6vBsam2r1mN5cX379cJeMYhQQQXPWJyUoNRqeAYK0CTENTELkVugRvy7SSOte2kjZzlfXa-HnmUql9YQ1UmD45yN6wgyY07i3jusjtQuhKWy8x8s915guQmgaHYhoHZsY-Pe6sgpFjnEZdPCjMNUgNKqpBRTXM2NlOeD1Qa_xd7JxUtBMhPux4Aa1EjVai_mUlM3ZKClZDc-nOq9US8yWUL0t8zMcoQX6Nrwx6bE_ADyeGrInk0UQS_REmyx8ejUjREhWxNS5sOiUKQucFIsYZKyfWNfm46Uqzuo-k3zKnSmDx7n_sxnv2TFBpDk3CKI7YQd9u3DFiq96cRDf6Bf_NJvs priority: 102 providerName: Directory of Open Access Journals |
| Title | A randomized trial to evaluate the impact of copra meal hydrolysate on gastrointestinal symptoms and gut microbiome |
| URI | https://www.proquest.com/docview/2580025727 https://pubmed.ncbi.nlm.nih.gov/PMC8449532 https://doaj.org/article/202a01f8c20b48138e2b06e8b963dccf |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9tAEF7SBEovpU_qJnW3ECgUlMoryVqdilOShoJDKTX4tuxLjouldSUZ4v76zqxkU6U59KKDdvScnZ1vpJlvCDnFnDAGbiGwzOggNjYJ-FirgKUsig1MiMgX0k6vx1ez-Os8mR-QXTPO7gXW94Z22E9qVq3Obn9tP4HBA349SyEa-bi2tvrpaRL4A3IELilFC512ON8vyQCiQ0_JyZDnG1BH1tbq3T2-5508if-_S_Xd9Mm__NHlE_K4A5J00mr-KTmw5TPycNr9Kn9O6gkFN2RcsfxtDfXNOWjjaMfubSkAP9qWSFKXU-3WlaQFoEZ6szWVW21rFHIlXci6qRyySsBigFest8W6cUVN4ex0sWlosWzJnAr7gswuL358vgq6DguBBtzVBCpKpVYy1IDjMg0RaqhZbJhMdW7SMOMylibjJrKZyaXKR5ENucwTo3QGkZXV0UtyWLrSviJUJrEZM5lJk3MABSMZ5YnmEnuKQoSn1YB82L1ZoTv6ceyCsRIQhqAahFeD8GoYkNO98Lpl3bhf7BxVtBdBqmy_w1UL0VmeYCGT4SjnmoUq5qOIW6bCseUKlh6jdT4gb1HBoq073Ru8mEAoBfJpCpd57yVwEsIta9lVLsCDI3lWT_KkJwmmqnvD73aTSOAQ5reV1m1qwRIE7gmAyQFJe7Or93D9kXJ54_nAeYxJwuz1f5z9mDximJSDPTCSE3LYVBv7BlBVo4bk6Pzi-tv3of8qAdsv89HQW9Efn6colA |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+randomized+trial+to+evaluate+the+impact+of+copra+meal+hydrolysate+on+gastrointestinal+symptoms+and+gut+microbiome&rft.jtitle=PeerJ+%28San+Francisco%2C+CA%29&rft.au=Sathitkowitchai%2C+Witida&rft.au=Suratannon%2C+Narissara&rft.au=Keawsompong%2C+Suttipun&rft.au=Weerapakorn%2C+Wanlapa&rft.date=2021-09-15&rft.issn=2167-8359&rft.eissn=2167-8359&rft.volume=9&rft.spage=e12158&rft_id=info:doi/10.7717%2Fpeerj.12158&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2167-8359&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2167-8359&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2167-8359&client=summon |